logo1
  • Home
  • Oncology Products
  • Contact Us
  • Home
  • Products
  • Hertab 250mg Tabs 30s
  • LAPATINIB - HERTAB 250MG 30 TABLETS

  • Booking
LAPATINIB - HERTAB 250MG 30 TABLETS

Hertab 250mg Tabs 30s

Composition : NA
Tweet

Description

HERTAB (Lapatinib) is an oral therapy indicated for the treatment of postmenopausal women with HER2-positive advanced breast cancer patients whose disease has progressed after taking Trastuzumab therapy.


Specifications

HERTAB (Lapatinib) is an oral therapy indicated for the treatment of postmenopausal women with HER2-positive advanced breast cancer patients whose disease has progressed after taking Trastuzumab therapy. Lapatinib is used in combination with other medication Capecitabine or Letrozole, which together, inhibit the growth of cancer cells in patients. Hetero has launched generic Lapatinib tablets, used in the treatment of advanced or metastatic breast cancer in the country. The tablets, under the brand name 'Hertab', have been launched in the strength of 250 mg, the product is marketed and distributed by Hetero Healthcare Ltd and has been made available in two stock keeping units (SKUs). The tablets are used in combination with Capecitabine or Letrozole, which together inhibit the growth of cancer cells in patient.


Uses

    Used to treat breast cancer.

Product Enquiry


Follow us
Contact with Us

Oncology Medicine Supplier,
      Madhapur, Hyderabad.

  • +91 90741 85510
  •      +91 96760 96969

Copyright © All Rights Reserved by Oncology Medicines.